We’re establishing a brand-new Intracellular Drug Delivery Centre, alongside our partners, to develop novel RNA-based vaccines and therapeutics.
NiTech Solutions’ CatContiCryst wins funding from UKRI’s Faraday Battery Challenge to develop a new technology for Li-ion batteries for electric vehicles.
A first-of-its-kind wearable device for stroke survivors could help up to 50% of stroke survivors recover movement in their arms and hands.
CPI Enterprises invests in disruptive deep tech company, Descycle, who offer a clean and efficient metal processing alternative to traditional smelting.
CPI is set to boost oligonucleotide manufacture through a £2.7 million 3‑year partnership with AstraZeneca, Novartis, and The University of Manchester.
CPI will share £27.6 million in funding from UKRI’s Faraday Battery Challenge to deliver the next generation of batteries for electric vehicles.
CPI Enterprises, the venture capital and investor engagement arm of CPI, has made its latest investment into Q5D – a leader in wire harness automation.
Up to 24% of UK-based HealthTech SMEs launch their innovations in the US, rather than the UK, due to its market size and favourable regulatory environment.
We’re helping NeoVac fast-track its lipid nanoparticle technology to clinical trials, to make RNA products more transportable, and have fewer side effects.
Page 1 of 72
To find out more about how we can work together, please enter your details below.